Decay accelerating factor (DAF) and nucleic acid encoding it
US6632634B1 · kind B1 · utility
0Cited by
10References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 1998 |
| Grant date | Oct 14, 2003 |
| Priority date | — |
| Expiry date | Jan 27, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/829
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel fusions of a GPI signal domain and a polypeptide heterologous to the GPI signal domain donor polypeptide are provided for industrial use. Therapeutic administration of the GPI-linked product of the fusions enables the targeting of biological activity to cell membrane surfaces.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.